annual D&A:
$41.70M-$144.00K(-0.34%)Summary
- As of today (September 9, 2025), AKBA annual depreciation & amortization is $41.70 million, with the most recent change of -$144.00 thousand (-0.34%) on December 31, 2024.
- During the last 3 years, AKBA annual D&A has risen by +$5.57 million (+15.43%).
- AKBA annual D&A is now -0.34% below its all-time high of $41.85 million, reached on December 31, 2023.
Performance
AKBA Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$316.00K+$2000.00(+0.64%)Summary
- As of today (September 9, 2025), AKBA quarterly depreciation & amortization is $316.00 thousand, with the most recent change of +$2000.00 (+0.64%) on June 1, 2025.
- Over the past year, AKBA quarterly D&A has dropped by -$9.09 million (-96.64%).
- AKBA quarterly D&A is now -97.68% below its all-time high of $13.62 million, reached on December 31, 2023.
Performance
AKBA quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$23.55M-$9.09M(-27.86%)Summary
- As of today (September 9, 2025), AKBA TTM depreciation & amortization is $23.55 million, with the most recent change of -$9.09 million (-27.86%) on June 1, 2025.
- Over the past year, AKBA TTM D&A has dropped by -$19.22 million (-44.95%).
- AKBA TTM D&A is now -44.95% below its all-time high of $42.77 million, reached on June 30, 2024.
Performance
AKBA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AKBA Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.3% | -96.6% | -45.0% |
| 3 y3 years | +15.4% | -96.4% | -34.1% |
| 5 y5 years | +14.5% | -96.7% | -35.4% |
AKBA Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.3% | +18.2% | -97.7% | +0.6% | -45.0% | at low |
| 5 y | 5-year | -0.3% | +24.1% | -97.7% | +0.6% | -45.0% | at low |
| alltime | all time | -0.3% | >+9999.0% | -97.7% | >+9999.0% | -45.0% | >+9999.0% |
AKBA Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $316.00K(+0.6%) | $23.55M(-27.9%) |
| Mar 2025 | - | $314.00K(-97.7%) | $32.64M(-21.7%) |
| Dec 2024 | $41.70M(-0.3%) | $13.54M(+44.5%) | $41.70M(-0.2%) |
| Sep 2024 | - | $9.37M(-0.4%) | $41.78M(-2.3%) |
| Jun 2024 | - | $9.41M(+0.4%) | $42.77M(+2.3%) |
| Mar 2024 | - | $9.38M(-31.2%) | $41.81M(-0.1%) |
| Dec 2023 | $41.85M(+18.6%) | $13.62M(+31.5%) | $41.85M(+18.8%) |
| Sep 2023 | - | $10.36M(+22.6%) | $35.23M(-0.7%) |
| Jun 2023 | - | $8.45M(-10.2%) | $35.48M(-0.9%) |
| Mar 2023 | - | $9.41M(+34.4%) | $35.82M(+1.5%) |
| Dec 2022 | $35.28M(-2.3%) | $7.00M(-34.1%) | $35.28M(-5.4%) |
| Sep 2022 | - | $10.62M(+20.9%) | $37.30M(+4.4%) |
| Jun 2022 | - | $8.79M(-1.0%) | $35.72M(-0.7%) |
| Mar 2022 | - | $8.87M(-1.7%) | $35.97M(-0.4%) |
| Dec 2021 | $36.13M(+7.6%) | $9.03M(-0.1%) | $36.13M(+3.7%) |
| Sep 2021 | - | $9.03M(-0.0%) | $34.83M(+7.4%) |
| Jun 2021 | - | $9.04M(+0.1%) | $32.41M(-1.8%) |
| Mar 2021 | - | $9.03M(+16.9%) | $32.99M(-1.8%) |
| Dec 2020 | $33.59M(-7.8%) | $7.72M(+16.7%) | $33.59M(+0.8%) |
| Sep 2020 | - | $6.62M(-31.2%) | $33.32M(-8.5%) |
| Jun 2020 | - | $9.62M(-0.0%) | $36.44M(-0.2%) |
| Mar 2020 | - | $9.63M(+29.1%) | $36.50M(+0.2%) |
| Dec 2019 | $36.42M | $7.46M(-23.4%) | $36.42M(+18.5%) |
| Sep 2019 | - | $9.73M(+0.5%) | $30.74M(+44.8%) |
| Jun 2019 | - | $9.69M(+1.6%) | $21.23M(+80.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $9.54M(+435.0%) | $11.76M(+385.8%) |
| Dec 2018 | $2.42M(+292.4%) | $1.78M(+692.4%) | $2.42M(+189.9%) |
| Sep 2018 | - | $225.00K(+5.1%) | $835.00K(+7.5%) |
| Jun 2018 | - | $214.00K(+7.5%) | $777.00K(+14.1%) |
| Mar 2018 | - | $199.00K(+1.0%) | $681.00K(+10.4%) |
| Dec 2017 | $617.00K(+108.4%) | $197.00K(+18.0%) | $617.00K(+13.4%) |
| Sep 2017 | - | $167.00K(+41.5%) | $544.00K(+15.5%) |
| Jun 2017 | - | $118.00K(-12.6%) | $471.00K(+18.0%) |
| Mar 2017 | - | $135.00K(+8.9%) | $399.00K(+34.8%) |
| Dec 2016 | $296.00K(+208.3%) | $124.00K(+31.9%) | $296.00K(+61.7%) |
| Sep 2016 | - | $94.00K(+104.3%) | $183.00K(+47.6%) |
| Jun 2016 | - | $46.00K(+43.8%) | $124.00K(+13.8%) |
| Mar 2016 | - | $32.00K(+190.9%) | $109.00K(+13.5%) |
| Dec 2015 | $96.00K(+95.9%) | $11.00K(-68.6%) | $96.00K(-5.0%) |
| Sep 2015 | - | $35.00K(+12.9%) | $101.00K(+28.0%) |
| Jun 2015 | - | $31.00K(+63.2%) | $78.90K(+31.7%) |
| Mar 2015 | - | $19.00K(+18.8%) | $59.90K(+22.2%) |
| Dec 2014 | $49.00K(+3669.2%) | $16.00K(+24.0%) | $49.00K(+42.9%) |
| Sep 2014 | - | $12.90K(+7.5%) | $34.30K(+60.3%) |
| Jun 2014 | - | $12.00K(+48.1%) | $21.40K(+127.7%) |
| Mar 2014 | - | $8100.00(+523.1%) | $9400.00(+623.1%) |
| Dec 2013 | $1300.00(-96.7%) | $1300.00(>+9900.0%) | $1300.00(>+9900.0%) |
| Sep 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2011 | $39.20K | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual D&A year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Akebia Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM D&A year-on-year change?
What is Akebia Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of AKBA is $41.70M
What is the all time high annual D&A for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual depreciation & amortization is $41.85M
What is Akebia Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, AKBA annual depreciation & amortization has changed by -$144.00K (-0.34%)
What is Akebia Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of AKBA is $316.00K
What is the all time high quarterly D&A for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly depreciation & amortization is $13.62M
What is Akebia Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, AKBA quarterly depreciation & amortization has changed by -$9.09M (-96.64%)
What is Akebia Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of AKBA is $23.55M
What is the all time high TTM D&A for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM depreciation & amortization is $42.77M
What is Akebia Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, AKBA TTM depreciation & amortization has changed by -$19.22M (-44.95%)